Nuvalent (NUVL)
Developer of selective kinase inhibitors targeting ROS1 and ALK resistance in lung cancer.
$123.96
0.00 (0.00%)
Delisted · Jul 16, 2026
Something off on this page? Send us feedback.
EPSReportedEstimate
Aug '24Nov '24Feb '25May '25Aug '25Oct '25Feb '26May '26
Reported−$0.88−$1.28−$1.05−$1.18−$1.31−$1.70−$1.29−$1.39
Estimate−$0.76−$0.93−$1.04−$1.14−$1.27−$1.39−$1.48−$1.35
Surprise−15.8%−37.0%−1.0%−3.5%−3.1%−22.3%+12.8%−3.0%
RevenueReportedEstimate
Aug '24Nov '24Feb '25May '25Aug '25Oct '25Feb '26May '26
Reported————————
Estimate——————$6.8M$486.0K
Surprise————————
HistoryUpcoming
| Date / Period | Estimate | Reported | Surprise |
|---|---|---|---|
| Dec 2027 | −$0.82 | — | — |
| Sep 2027 | −$1.11 | — | — |
| Jun 2027 | −$1.26 | — | — |
| Mar 2027 | −$0.97 | — | — |
| Dec 2026 | −$1.42 | — | — |
| Sep 2026 | −$1.44 | — | — |
| Aug 2026 | −$1.44 | — | — |
| May 2026 | −$1.35 | −$1.39 | −3.0% |
| Feb 2026 | −$1.48 | −$1.29 | +12.8% |
| Oct 2025 | −$1.39 | −$1.70 | −22.3% |
| Aug 2025 | −$1.27 | −$1.31 | −3.1% |
| May 2025 | |||
| Feb 2025 | |||
| Nov 2024 | |||
| Aug 2024 | |||
| May 2024 | |||
| Feb 2024 | |||
| Nov 2023 | |||
| Aug 2023 | |||
| May 2023 | |||
| Mar 2023 | |||
| Nov 2022 | |||
| Aug 2022 | |||
| May 2022 | |||
| Nov 2021 | |||
| Sep 2021 | |||
| Dec 2020 | |||
| Sep 2020 | |||
| Jun 2020 | |||
| Mar 2020 |
| Date / Period | EPS est | EPS | Surprise | Revenue est | Revenue | Surprise | Reaction |
|---|---|---|---|---|---|---|---|
| Dec 2027 | −$0.82 | — | — | $62.9M | — | — | — |
| Sep 2027 | −$1.11 | — | — | $45.4M | — | — | — |
| Jun 2027 | −$1.26 | — | — | $31.7M | — | — | — |
| Mar 2027 | −$0.97 | — | — | $49.9M | — | — | — |
| Dec 2026 | −$1.42 | — | — | $9.9M | — | — | — |
| Sep 2026 | −$1.44 | — | — | $2.2M | — | — | — |
| Aug 6, 2026 | −$1.44 | — | — | $245.5K | — | — | — |
| May 7, 2026 | −$1.35 | −$1.39 | −3.0% | $486.0K | — | — | +2.8% |
| Feb 26, 2026 | −$1.48 | −$1.29 | +12.8% | $6.8M | — | — | −1.9% |
| Oct 30, 2025 | −$1.39 | −$1.70 | −22.3% | — | — | — | +1.2% |
| Aug 7, 2025 | −$1.27 | −$1.31 | −3.1% | — | — | — | +2.7% |
| May 8, 2025 | |||||||
| Feb 27, 2025 | |||||||
| Nov 12, 2024 | |||||||
| Aug 8, 2024 | |||||||
| May 9, 2024 | |||||||
| Feb 27, 2024 | |||||||
| Nov 14, 2023 | |||||||
| Aug 10, 2023 | |||||||
| May 11, 2023 | |||||||
| Mar 16, 2023 | |||||||
| Nov 10, 2022 | |||||||
| Aug 10, 2022 | |||||||
| May 12, 2022 | |||||||
| Nov 10, 2021 | |||||||
| Sep 8, 2021 | |||||||
| Dec 31, 2020 | |||||||
| Sep 30, 2020 | |||||||
| Jun 30, 2020 | |||||||
| Mar 31, 2020 |